- Investing Ideas
- /
- German Pharmaceuticals & Biotech Strong Balance Sheet Stocks
German Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
16
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
16 companies
Merck KGaA
Market Cap: €50.1b
Operates as a science and technology company in Germany.
MRK
€115.30
7D
-2.1%
1Y
-24.9%
2invest
Market Cap: €69.6m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
2INV
€12.10
7D
-2.4%
1Y
40.7%
Cantourage Group
Market Cap: €57.2m
Operates as a medical cannabis company in Europe.
HIGH
€4.59
7D
9.8%
1Y
-43.0%
Apontis Pharma
Market Cap: €92.9m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPH
€11.15
7D
-1.3%
1Y
32.7%
SCHOTT Pharma KGaA
Market Cap: €3.3b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
1SXP
€22.10
7D
3.6%
1Y
-42.0%
PharmaSGP Holding
Market Cap: €292.6m
Manufactures and sells over-the-counter drugs and other healthcare products in Germany.
PSG
€24.40
7D
0.8%
1Y
8.9%
Liminal BioSciences
Market Cap: €11.8m
Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.
PJ2
€3.80
7D
0%
1Y
-0.7%
4SC
Market Cap: €27.3m
A biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany.
VSC
€2.50
7D
0%
1Y
-69.6%
Formycon
Market Cap: €382.3m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€21.65
7D
-5.5%
1Y
-53.4%
Medigene
Market Cap: €3.1m
A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.
MDG1
€0.21
7D
-68.3%
1Y
-94.9%
bioXXmed
Market Cap: €308.2k
An investment company, invests in biotechnology or medical technology companies with equity or debt capital.
T5O0
€0.60
7D
-14.3%
1Y
-87.3%
Evotec
Market Cap: €950.4m
Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
EVT
€5.35
7D
-2.9%
1Y
-61.1%
Heidelberg Pharma
Market Cap: €120.2m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally.
HPHA
€2.58
7D
-8.2%
1Y
-15.4%
MPH Health Care
Market Cap: €95.0m
An investment company, engages in the healthcare business in Germany.
93M1
€22.20
7D
0.9%
1Y
9.9%
Biofrontera
Market Cap: €14.9m
A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.
B8FK
€2.46
7D
-1.0%
1Y
-65.5%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany.
DMP
€36.55
7D
2.8%
1Y
9.1%